相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Matrine involves in the progression of gastric cancer through inhibiting miR-93-5p and upregulating the expression of target gene AHNAK
Zhi-Min Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
The basics of epithelial-mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective
Vishal Das et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Therapeutic Potential of a Novel αvβ3 Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type
Billy Samuel Hill et al.
CANCERS (2019)
New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
Noura Khaled et al.
CANCERS (2019)
Overexpression of ANLN in lung adenocarcinoma is associated with metastasis
Jie Xu et al.
THORACIC CANCER (2019)
14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling
Jing Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer
Buse Cevatemre et al.
PHARMACOLOGICAL RESEARCH (2018)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer
Jenny G. Parvani et al.
CANCER RESEARCH (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Pristimerin Inhibits Breast Cancer Cell Migration by Up-regulating Regulator of G Protein Signaling 4 Expression
Xian-Min Mu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Early events in cell adhesion and polarity during epithelial-mesenchymal transition
Ruby Yun-Ju Huang et al.
JOURNAL OF CELL SCIENCE (2012)
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Javier Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer
Vivek R. Yadav et al.
TOXINS (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria
CC Wu et al.
MOLECULAR CANCER THERAPEUTICS (2005)
分享论文
